MedTrace Logo

Monitoring of Cerebral Autoregulation in Pediatric ECMO (ECMOX 1)

NCT04282525 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2020-02-24

No results posted yet for this study

Summary

Children supported by Extra-Corporeal Membrane Oxygenation (ECMO) present a high risk of neurological complications and cerebral autoregulation (CA) impairment may be a risk factor. Our first objective is to investigate the feasibility of CA continuous monitoring during ECMO treatment. The second objective is to analyze the relationship between CA impairment and neurological outcome.

Conditions

  • Extracorporeal Membrane Oxygenation Complication

Interventions

OTHER

ECMO for hemodynamic or respiratory indication

ECMO for hemodynamic or respiratory indication

Sponsors & Collaborators

  • Istituto Giannina Gaslini

    collaborator OTHER

  • University of Cambridge

    collaborator OTHER

  • Nantes University Hospital

    lead OTHER

Eligibility

Min Age
1 Day
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2019-06-01
Completion
2019-06-01

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04282525 on ClinicalTrials.gov